In an APP/PS1 transgenic mouse model of Alzheimer's disease, inhibition of HDAC3 in the hippocampus alleviated microglial activation, which showed therapeutic potential for Alzheimer's disease 163. This evidence concerns the gene HDAC3 and early-onset autosomal dominant Alzheimer disease.